What is the efficacy of glycopyrrolate cream versus Drysol (aluminum chloride) or oral glycopyrrolate for treating hyperhidrosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Efficacy of Glycopyrrolate Cream versus Drysol or Oral Glycopyrrolate for Hyperhidrosis

Topical glycopyrrolate cream is the most effective first-line treatment for craniofacial hyperhidrosis, while aluminum chloride (Drysol) remains the first-line treatment for axillary hyperhidrosis, and oral glycopyrrolate should be reserved for cases unresponsive to topical treatments due to its systemic side effects. 1

Treatment Selection Based on Affected Area

Craniofacial Hyperhidrosis

  • First-line: Topical glycopyrrolate (2%)
    • Complete response in 75% of cases 2
    • Faster onset but shorter duration compared to botulinum toxin 2
    • Excellent or good anhidrosis in 88% of patients 3
    • Duration of effect: 1-4 days before recurrence 3
    • Particularly effective for facial sweating with minimal side effects 4

Axillary Hyperhidrosis

  • First-line: Topical aluminum chloride (Drysol, 15% solution)
    • 72% response rate in moderate-to-severe cases 1
    • Application technique is critical:
      • Apply to completely dry skin
      • Apply at bedtime
      • Wash off in the morning
    • Common side effect: skin irritation

Palmar and Plantar Hyperhidrosis

  • First-line: Iontophoresis
    • Treatment sessions: 20-30 minutes, 3-4 times weekly initially
    • Maintenance: 1-2 times weekly 1

Comparative Efficacy

Topical Glycopyrrolate vs. Aluminum Chloride (Drysol)

  • Topical glycopyrrolate (2%):

    • Superior for craniofacial hyperhidrosis 1
    • Less skin irritation than aluminum chloride
    • Shorter duration requiring more frequent application
    • Effective for gustatory hyperhidrosis (77% excellent response) 5
  • Aluminum chloride (Drysol):

    • More effective for axillary hyperhidrosis 1
    • Longer duration of action
    • Higher incidence of skin irritation
    • Less effective for craniofacial hyperhidrosis

Topical vs. Oral Glycopyrrolate

  • Topical glycopyrrolate:

    • Minimal systemic absorption
    • Few side effects (mild dry mouth, sore throat, occasional headache) 5
    • Localized effect
    • Can be applied as needed
  • Oral glycopyrrolate:

    • Significant systemic side effects including:
      • Dry mouth
      • Constipation
      • Blurred vision
      • Cognitive effects 1
    • Contraindicated in patients with:
      • Glaucoma
      • Myasthenia gravis
      • Significant bladder outflow obstruction 1
    • Improves quality of life and reduces anxiety in primary hyperhidrosis 6

Treatment Algorithm

  1. Identify the primary affected area:

    • Craniofacial → Topical glycopyrrolate 2%
    • Axillary → Aluminum chloride (Drysol) 15%
    • Palmar/plantar → Iontophoresis
  2. If first-line treatment fails after 4 weeks:

    • Consider botulinum toxin injections (effective but painful, requires repeated treatments every 3-9 months) 1
    • For axillary hyperhidrosis, consider microwave therapy 1
  3. If localized treatments fail:

    • Consider oral glycopyrrolate (1-2 mg once or twice daily) 1
    • Monitor for anticholinergic side effects
  4. Last resort for severe, treatment-resistant cases:

    • Surgical options: local procedures (curettage/liposuction) for axillary hyperhidrosis
    • Endoscopic thoracic sympathectomy (risk of compensatory hyperhidrosis) 1

Important Considerations

  • Treatment success should be measured using the Hyperhidrosis Disease Severity Scale (HDSS), with success defined as reduction to score <2 1
  • Patient education on proper application techniques is critical for topical treatments
  • Inadequate drying before applying aluminum chloride significantly reduces its effectiveness 1
  • Stopping treatment too soon can lead to symptom recurrence 1
  • Compensatory hyperhidrosis is a risk with surgical interventions 1

By selecting the appropriate treatment based on the affected area and severity of hyperhidrosis, clinicians can significantly improve patients' quality of life while minimizing side effects.

References

Guideline

Hyperhidrosis Diagnosis and Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Intradermal Botulinum Toxin A Injection Versus Topical 2% Glycopyrrolate for the Treatment of Primary Facial Hyperhidrosis: A Pilot Study and Review of Literature.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2022

Research

Topical glycopyrrolate for patients with facial hyperhidrosis.

The British journal of dermatology, 2008

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.